A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...
Proficio Capital Partners LLC increased its holdings in Eli Lilly by 30.2% during Q4, acquiring an additional 1,562 shares. Proficio now owns 6,739 shares of Eli Lilly, valued at $5.2 million. Several ...
Investors looking for safe havens in a dangerous market. China EV players, FedEx and Micron earnings next week.
3d
Barchart on MSNIs Amgen Stock a Buy, Sell, or Hold as Weight-Loss Drug Trials Kick Off?Amgen (AMGN) is a biotech company based in California. It specializes in developing treatments for cardiovascular conditions, ...
But as the drugstore chain (WBA) prepares to go private and its rival CVS Health Inc. (CVS) experiments with smaller stores, some analysts and researchers see a possible future with even fewer ...
In this article, we will look at the 10 Best Growth Stocks to Invest in for the Next 10 Years. On March 8, Ben Snider, ...
Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program ...
Eli Lilly (LLY) stock dropped by 0.22%, underperforming the S&P 500’s 0.49% gain. Over the past month, the stock has fallen 4 ...
A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...
MariTide’s opportunity in diabetes should not be ignored. In addition to reducing weight by 17%, it reduced HbA1c up to 2.2% ...
Stock splits tend to create a lot of buzz in the market, especially when some of the most prominent companies announce a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results